Showing results (81-90 of 123) with videos related to
Sort By:
Pageof 13
EMBO Molecular Medicine|October 22, 2014
Combined deletion of Pten and p53 in mammary epithelium accelerates triple-negative breast cancer with dependency on eEF2KJeff C Liu, Veronique Voisin, Sharon Wang, et al.Blood|July 11, 2009
Chelation of intracellular iron with the antifungal agent ciclopirox olamine induces cell death in leukemia and myeloma cellsYanina Eberhard, Sean P McDermott, Xiaoming Wang, et al.Ebiomedicine|February 17, 2020
Amplification of a calcium channel subunit CACNG4 increases breast cancer metastasisNisha Kanwar, Katia Carmine-Simmen, Ranju Nair, et al.Antioxidants (Basel, Switzerland)|January 20, 2019
KRIT1 Loss-Of-Function Associated with Cerebral Cavernous Malformation Disease Leads to Enhanced <i>S</i>-Glutathionylation of Distinct Structural and Regulatory ProteinsLaura Cianfruglia, Andrea Perrelli, Claudia Fornelli, et al.The Journal of Cell Biology|January 13, 2010
Integrating high-throughput genetic interaction mapping and high-content screening to explore yeast spindle morphogenesisFranco J Vizeacoumar, Nydia van Dyk, Frederick S Vizeacoumar, et al.Nature Communications|July 27, 2024
High-throughput sensitive screening of small molecule modulators of microexon alternative splicing using dual Nano and Firefly luciferase reportersAndrew J Best, Ulrich Braunschweig, Mingkun Wu, et al.Cancer Research|March 19, 2009
Inhibition of the sodium potassium adenosine triphosphatase pump sensitizes cancer cells to anoikis and prevents distant tumor formationCraig D Simpson, Imtiaz A Mawji, Kika Anyiwe, et al.Blood|July 21, 2010
The antiparasitic agent ivermectin induces chloride-dependent membrane hyperpolarization and cell death in leukemia cellsSumaiya Sharmeen, Marko Skrtic, Mahadeo A Sukhai, et al.Experimental Neurology|September 24, 2018
Early intrathecal infusion of everolimus restores cognitive function and mood in a murine model of Alzheimer's diseaseTommaso Cassano, Alessandro Magini, Stefano Giovagnoli, et al.Plos One|November 13, 2018
Lestaurtinib is a potent inhibitor of anaplastic thyroid cancer cell line modelsNicole Pinto, Stephenie D Prokopec, Frederick Vizeacoumar, et al.Pageof 13